Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome.
Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY
A translational study for identification of prognostic and treatment-predictive biomarkers in Mycosis fungoides and Sézary syndrome.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 100
Healthy Volunteers: t
View:
• Age 18-100 years
• Histologically confirmed (according to the World Health Organization (WHO)/EORTC classification) MF/SS stages I-IV
• WHO performance status 0 -3
• Absence of psychiatric illness or condition which could interfere with the subjects' ability to understand the requirements of the study.
• Written informed consent according to International Conference on Harmonization (ICH)/(Good Clinical Practice (GCP), and Swedish regulations
• No minimum or maximum required routine laboratory data
Locations
Other Locations
Sweden
Lund University Hospital
RECRUITING
Lund
Time Frame
Start Date: 2021-04-02
Estimated Completion Date: 2027-04
Participants
Target number of participants: 120
Treatments
Patients with Mycosis fungoides and Sézary syndrome
Healthy volontaires
Related Therapeutic Areas
Sponsors
Leads: Lund University Hospital